Article Text

Download PDFPDF
Palliative care in advanced coronavirus disease in intensive care units
  1. Ali Esmaeili Vardanjani1,
  2. Hossein Rafiei2 and
  3. Mostafa Mohammdi3
  1. 1 Department of Critical Care nursing & Management, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Tehran, Iran (the Islamic Republic of)
  2. 2 Department of Critical Care Nursing, School of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin, Iran (the Islamic Republic of)
  3. 3 Anesthesiology and Intensive Care, Department of Intensive Care Unit, Imam Khomeini Hospital, faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  1. Correspondence to Hossein Rafiei, -, Qazvin, Iran (the Islamic Republic of); Hosseinr21{at}gmail.com

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Coronavirus disease (COVID-19) is rapidly developing throughout the world.1 Although many do not have severe symptoms, a minority (about 5%) develop an advanced form and are admitted to intensive care units.2 There is no known cure, and a significant proportion die in these units. Iran is one of those countries struggling with the disease.3 Our experience shows that in addition to the therapeutic measures, palliative care is also required.

These patients suffer during the last days of their lives in intensive care units. Severe symptoms, body pain, dry cough, death anxiety, chills, fear of imminent death, gastrointestinal problems and shortness of breath affect …

View Full Text

Footnotes

  • Contributors AEV: planning, conduct and article writing; HR: planning, article writing, conduct and article submission; MM: planning and article writing.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; internally peer reviewed.